These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23222175)

  • 21. Xenotransplantation: a challenge for the future of transplant medicine.
    Remuzzi G
    Schweiz Med Wochenschr; 1998 Jun; 128(24):952-60. PubMed ID: 9674059
    [No Abstract]   [Full Text] [Related]  

  • 22. Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.
    Ringdén O
    Stem Cells Dev; 2009 Nov; 18(9):1243-6. PubMed ID: 19905962
    [No Abstract]   [Full Text] [Related]  

  • 23. Complement-here, there and everywhere, but what about the transplanted organ?
    Montero RM; Sacks SH; Smith RA
    Semin Immunol; 2016 Jun; 28(3):250-9. PubMed ID: 27179705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusion proteins in immunointervention.
    Parker KE; Giral M; Soulillou JP
    Transplant Proc; 1992 Dec; 24(6):2362-5. PubMed ID: 1465797
    [No Abstract]   [Full Text] [Related]  

  • 25. Has effective immunosuppression eliminated the need for transplant immunology?
    Calne R
    Transplant Proc; 1992 Dec; 24(6):2366-8. PubMed ID: 1465798
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of new non-nephrotoxic immunosuppressive drugs in kidney transplantation, especially after ischemia-reperfusion injury].
    Charpentier B; Beaudreuil S; Francois H; Jacquet A; Durrbach A
    Bull Acad Natl Med; 2011; 195(4-5):899-912; discussion 912. PubMed ID: 22375359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tubular regeneration and the role of bone marrow cells: 'stem cell therapy'--a panacea?
    De Broe ME
    Nephrol Dial Transplant; 2005 Nov; 20(11):2318-20. PubMed ID: 16188893
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular imaging in transplantation: basic concepts and strategies for potential application.
    Kanderi T; Moore WH; Wendt JA
    Nucl Med Commun; 2005 Nov; 26(11):947-55. PubMed ID: 16208171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New paradigms in immunosuppression.
    Huizinga R; Voyer T
    CANNT J; 2003; 13(3):66-8. PubMed ID: 14596200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies.
    Komoda H; Okura H; Lee CM; Sougawa N; Iwayama T; Hashikawa T; Saga A; Yamamoto-Kakuta A; Ichinose A; Murakami S; Sawa Y; Matsuyama A
    Tissue Eng Part A; 2010 Apr; 16(4):1143-55. PubMed ID: 19863253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The coin toss of B cells in rejection and tolerance: danger versus defense.
    Zarkhin V; Sarwal MM
    Semin Immunol; 2012 Apr; 24(2):86-91. PubMed ID: 22035649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation recent advances in transplantation immunology.
    Gluckman E
    Curr Opin Immunol; 2006 Oct; 18(5):556-8. PubMed ID: 16893635
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
    Wan CD; Cheng R; Wang HB; Liu T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of mesenchymal stem cell-derived microvesicles.
    Biancone L; Bruno S; Deregibus MC; Tetta C; Camussi G
    Nephrol Dial Transplant; 2012 Aug; 27(8):3037-42. PubMed ID: 22851627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging role of microvesicles in cellular therapies for organ/tissue regeneration.
    Ratajczak MZ
    Nephrol Dial Transplant; 2011 May; 26(5):1453-6. PubMed ID: 21531733
    [No Abstract]   [Full Text] [Related]  

  • 37. The clinical role of OKT3.
    Norman DJ
    Cardiol Clin; 1990 Feb; 8(1):97-105. PubMed ID: 2407364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Xenotransplantation of solid organs: study of rejection mechanisms and its prevention].
    Rodríguez Villa A; Torres de Rueda A; Angulo Sánchez M; Alvarez Rivas MA; Rojas Contreras R; Torres Gómez A
    Rev Clin Esp; 1998 Oct; 198(10):673-7. PubMed ID: 9844457
    [No Abstract]   [Full Text] [Related]  

  • 39. [Graft immunity in lung transplantation].
    Mornex JF
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):257-66. PubMed ID: 12844023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection.
    Huang Y; Chen P; Zhang CB; Ko GJ; Ruiz M; Fiorina P; Hussain MA; Wasowska BA; Rabb H; Womer KL
    Transplantation; 2010 Dec; 90(12):1307-11. PubMed ID: 21048532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.